Detalhe da pesquisa
1.
Functional interrogation of lymphocyte subsets in alopecia areata using single-cell RNA sequencing.
Proc Natl Acad Sci U S A
; 120(29): e2305764120, 2023 07 18.
Artigo
Inglês
| MEDLINE | ID: mdl-37428932
2.
Two Phase 3 Trials of Baricitinib for Alopecia Areata.
N Engl J Med
; 386(18): 1687-1699, 2022 05 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35334197
3.
Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial.
Lancet
; 401(10387): 1518-1529, 2023 05 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37062298
4.
A clinical investigation of early-onset alopecia areata in children: Onset earlier than 4 years of age might have a better short-term prognosis.
Exp Dermatol
; 33(1): e14991, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38284194
5.
Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update.
Pharmacol Res
; 200: 107059, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38216005
6.
A Bibliometrics of the Treatment of Alopecia Areata in the Past Twenty Years.
Dermatology
; 240(1): 42-58, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-37939681
7.
Status of research on the development and regeneration of hair follicles.
Int J Med Sci
; 21(1): 80-94, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38164355
8.
Effect of minoxidil combined with triamcinolone acetonide on alopecia areata by microneedle injection.
Skin Res Technol
; 30(4): e13713, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38634160
9.
MiR-200c-3p as a novel genetic marker and therapeutic tool for alopecia areata.
Skin Res Technol
; 30(3): e13639, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38454571
10.
European expert consensus statement on the systemic treatment of alopecia areata.
J Eur Acad Dermatol Venereol
; 38(4): 687-694, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38169088
11.
Long-term efficacy and safety of baricitinib in patients with severe alopecia areata: 104-week results from BRAVE-AA1 and BRAVE-AA2.
J Eur Acad Dermatol Venereol
; 38(3): 583-593, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38391212
12.
Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: A systematic review and Bayesian network meta-analysis.
J Eur Acad Dermatol Venereol
; 38(5): 835-843, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38279559
13.
Improvement of severe alopecia areata in an adolescent patient on upadacitinib.
Pediatr Dermatol
; 41(2): 356-358, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38151479
14.
The role of laser and energy-assisted drug delivery in the treatment of alopecia.
Lasers Med Sci
; 39(1): 73, 2024 Feb 21.
Artigo
Inglês
| MEDLINE | ID: mdl-38381230
15.
CXCL12 Neutralizing Antibody Promotes Hair Growth in Androgenic Alopecia and Alopecia Areata.
Int J Mol Sci
; 25(3)2024 Jan 30.
Artigo
Inglês
| MEDLINE | ID: mdl-38338982
16.
Application of validated UV spectrophotometric and colorimetric method to quantify minoxidil in the development of trilayer dissolving microneedle: Proof of concept in ex vivo and in vivo studies in rats.
Ann Pharm Fr
; 82(3): 531-544, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38135037
17.
[Dermatology. New uses for JAK inhibitors in dermatology: a panacea, but at what price?] / Dermatologie. Nouvelles utilisations des inhibiteurs de JAK en dermatologie : panacée mais à quel prix ?
Rev Med Suisse
; 20(859): 241-246, 2024 Jan 31.
Artigo
Francês
| MEDLINE | ID: mdl-38299954
18.
Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata.
Allergy
; 78(4): 1047-1059, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36271804
19.
Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials.
Br J Dermatol
; 188(2): 218-227, 2023 02 10.
Artigo
Inglês
| MEDLINE | ID: mdl-36763878
20.
When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials.
Br J Dermatol
; 189(6): 666-673, 2023 Nov 16.
Artigo
Inglês
| MEDLINE | ID: mdl-37708254